New Directions in the Treatment of Pancreatic Cancer

Dear Colleagues,

The progress of medicine in pancreatic cancer and the skill to perform more complex diagnostic and surgical procedures have significantly improved the results of the treatment, although traditionally, pancreatic cancer surgery has been considered one of the most challenging. Better imaging techniques, such as MRI, CT scans, PET scans, and endoscopic ultrasonography, can help in accurately staging pancreatic cancer. This information guides surgeons in determining the extent of resection needed and whether the tumor is resectable or not. Today, neoadiuvant chemotherapy and minimally invasive surgery, such as laparoscopic or robotically assisted pancreatectomy, are usually available in common clinical practice. In advanced cases where complete removal of the tumor is not possible, innovation in palliative treatment can alleviate symptoms and improve the quality of life. A team of specialists, including surgeons, oncologists, radiologists, and pathologists, collaborates to create tailored approaches for pancreatic cancer. Surgical treatment plays a crucial role in managing pancreatic cancer, and different procedures are used based on the location and stage of the tumor.

In this Special Issue, we welcome authors to submit papers on the clinical advances in the treatment of pancreatic cancer in terms of both diagnosis and treatment.

Dr. Roberto Cirocchi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• pancreatic cancer
• pancreatic ductal adenocarcinoma
• pancreatoduodenectomy
• distal pacreasectomy
• biliary drainage
• endoscopic biliary drainage
• endoscopic biliary stenting
• neoadjuvant chemotherapy